Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 132

1.

Structural and functional properties of a probabilistic model of neuronal connectivity in a simple locomotor network.

Ferrario A, Merrison-Hort R, Soffe SR, Borisyuk R.

Elife. 2018 Mar 28;7. pii: e33281. doi: 10.7554/eLife.33281.

2.

Reducing rates of Clostridium difficile infection by switching to a stand-alone NAAT with clear sampling criteria.

Casari E, De Luca C, Calabrò M, Scuderi C, Daleno C, Ferrario A.

Antimicrob Resist Infect Control. 2018 Mar 12;7:40. doi: 10.1186/s13756-018-0332-2. eCollection 2018.

3.

Rational drug design and synthesis of new α-Santonin derivatives as potential COX-2 inhibitors.

Coricello A, El-Magboub A, Luna M, Ferrario A, Haworth IS, Gomer CJ, Aiello F, Adams JD.

Bioorg Med Chem Lett. 2018 Apr 1;28(6):993-996. doi: 10.1016/j.bmcl.2018.02.036. Epub 2018 Feb 22.

PMID:
29501395
4.

Drug promotional activities in Nigeria: impact on the prescribing patterns and practices of medical practitioners and the implications.

Fadare JO, Oshikoya KA, Ogunleye OO, Desalu OO, Ferrario A, Enwere OO, Adeoti A, Sunmonu TA, Massele A, Baker A, Godman B.

Hosp Pract (1995). 2018 Apr;46(2):77-87. doi: 10.1080/21548331.2018.1437319. Epub 2018 Feb 20.

PMID:
29426263
5.

Secondary acute myeloid leukaemia in elderly patients: Patient's fitness criteria and ELN prognostic stratification can be applied to guide treatment decisions. An analysis of 280 patients by the network rete ematologica lombarda (REL).

Borlenghi E, Pagani C, Zappasodi P, Bernardi M, Basilico C, Todisco E, Fracchiolla N, Mancini V, Turrini M, Da Vià M, Sala E, Cattaneo C, Petullà M, Serana F, Ferrario A, Cairoli R, Cortelezzi A, Santoro A, Castagnola C, Rossi G.

Am J Hematol. 2018 Feb;93(2):E54-E57. doi: 10.1002/ajh.24977. Epub 2017 Dec 4. No abstract available.

PMID:
29164738
6.

Strategic procurement and international collaboration to improve access to medicines.

Ferrario A, Humbert T, Kanavos P, Pedersen HB.

Bull World Health Organ. 2017 Oct 1;95(10):720-722. doi: 10.2471/BLT.16.187344. Epub 2017 Aug 23. No abstract available.

7.

Assessing Adherence to Antihypertensive Therapy in Primary Health Care in Namibia: Findings and Implications.

Nashilongo MM, Singu B, Kalemeera F, Mubita M, Naikaku E, Baker A, Ferrario A, Godman B, Achieng L, Kibuule D.

Cardiovasc Drugs Ther. 2017 Dec;31(5-6):565-578. doi: 10.1007/s10557-017-6756-8.

8.

Rabbit model of ocular indirect photodynamic therapy using a retinoblastoma xenograft.

Kim JW, Jacobsen B, Zolfaghari E, Ferrario A, Chevez-Barrios P, Berry JL, Lee DK, Rico G, Madi I, Rao N, Stachelek K, Wang LC, Gomer C.

Graefes Arch Clin Exp Ophthalmol. 2017 Dec;255(12):2363-2373. doi: 10.1007/s00417-017-3805-8. Epub 2017 Oct 2.

PMID:
28971251
9.

The value of innovation in decision-making in health care in Central Eastern Europe - The Sixth International Conference, 2 June 2017, Belgrade, Serbia.

Novakovic T, Martin AP, Parker M, Ferrario A, Vukovic S, Łanda K, Duba J, Dankó D, Kotsopoulos N, Godman B, Ristic J, Stefanovic D, Tesic D.

Expert Rev Pharmacoecon Outcomes Res. 2017 Dec;17(6):519-521. doi: 10.1080/14737167.2017.1385394. Epub 2017 Oct 9.

PMID:
28946800
10.

A rare genetic variant of BPIFB4 predisposes to high blood pressure via impairment of nitric oxide signaling.

Vecchione C, Villa F, Carrizzo A, Spinelli CC, Damato A, Ambrosio M, Ferrario A, Madonna M, Uccellatore A, Lupini S, Maciag A, Ryskalin L, Milanesi L, Frati G, Sciarretta S, Bellazzi R, Genovese S, Ceriello A, Auricchio A, Malovini A, Puca AA.

Sci Rep. 2017 Aug 29;7(1):9706. doi: 10.1038/s41598-017-10341-x.

11.

The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications.

Ferrario A, Arāja D, Bochenek T, Čatić T, Dankó D, Dimitrova M, Fürst J, Greičiūtė-Kuprijanov I, Hoxha I, Jakupi A, Laidmäe E, Löblová O, Mardare I, Markovic-Pekovic V, Meshkov D, Novakovic T, Petrova G, Pomorski M, Tomek D, Voncina L, Haycox A, Kanavos P, Vella Bonanno P, Godman B.

Pharmacoeconomics. 2017 Dec;35(12):1271-1285. doi: 10.1007/s40273-017-0559-4.

12.

LAV-BPIFB4 isoform modulates eNOS signalling through Ca2+/PKC-alpha-dependent mechanism.

Spinelli CC, Carrizzo A, Ferrario A, Villa F, Damato A, Ambrosio M, Madonna M, Frati G, Fucile S, Sciaccaluga M, Capunzo M, Calì G, Milanesi L, Maciag A, Puca AA, Vecchione C.

Cardiovasc Res. 2017 Jun 1;113(7):795-804. doi: 10.1093/cvr/cvx072.

13.

Siltuximab and hematologic malignancies. A focus in non Hodgkin lymphoma.

Ferrario A, Merli M, Basilico C, Maffioli M, Passamonti F.

Expert Opin Investig Drugs. 2017 Mar;26(3):367-373. doi: 10.1080/13543784.2017.1288213. Epub 2017 Feb 9. Review.

PMID:
28140696
14.

How Can Pricing and Reimbursement Policies Improve Affordable Access to Medicines? Lessons Learned from European Countries.

Vogler S, Paris V, Ferrario A, Wirtz VJ, de Joncheere K, Schneider P, Pedersen HB, Dedet G, Babar ZU.

Appl Health Econ Health Policy. 2017 Jun;15(3):307-321. doi: 10.1007/s40258-016-0300-z. Review.

PMID:
28063134
15.

Determinants of utilisation differences for cancer medicines in Belgium, Scotland and Sweden.

Ferrario A.

Eur J Health Econ. 2017 Dec;18(9):1095-1105. doi: 10.1007/s10198-016-0855-5. Epub 2016 Dec 9.

16.

A new acute myeloid leukemia case with STAT5B-RARA gene fusion due to 17q21.2 interstitial deletion.

Pessina C, Basilico C, Genoni A, Meroni E, Elli L, Granata P, Righi R, Pallotti F, Mora B, Ferrario A, Passamonti F, Casalone R.

Leuk Lymphoma. 2017 Aug;58(8):1977-1980. doi: 10.1080/10428194.2016.1262952. Epub 2016 Dec 2. No abstract available.

PMID:
27911132
17.

Emerging resistant bacteria strains in bloodstream infections of acute leukaemia patients: results of a prospective study by the Rete Ematologica Lombarda (Rel).

Cattaneo C, Zappasodi P, Mancini V, Annaloro C, Pavesi F, Skert C, Ferrario A, Todisco E, Saccà V, Verga L, Passi A, Da Vià M, Ferrari S, Mometto G, Petullà M, Nosari A, Rossi G.

Ann Hematol. 2016 Dec;95(12):1955-1963. Epub 2016 Sep 21.

PMID:
27650830
18.

Challenges in diabetes mellitus type 2 management in Nepal: a literature review.

Gyawali B, Ferrario A, van Teijlingen E, Kallestrup P.

Glob Health Action. 2016 Oct 18;9:31704. doi: 10.3402/gha.v9.31704. eCollection 2016. Review.

19.

New uses for brentuximab vedotin and novel antibody drug conjugates in lymphoma.

Merli M, Ferrario A, Maffioli M, Olivares C, Stasia A, Arcaini L, Passamonti F.

Expert Rev Hematol. 2016 Aug;9(8):767-80. doi: 10.1080/17474086.2016.1205949. Epub 2016 Jul 14. Review.

PMID:
27416486
20.

Targeting Survivin Enhances Chemosensitivity in Retinoblastoma Cells and Orthotopic Tumors.

Ferrario A, Luna M, Rucker N, Wong S, Lederman A, Kim J, Gomer C.

PLoS One. 2016 Apr 6;11(4):e0153011. doi: 10.1371/journal.pone.0153011. eCollection 2016.

21.

Pharmaceutical policies in a crisis? Challenges and solutions identified at the PPRI Conference.

Vogler S, Zimmermann N, Ferrario A, Wirtz VJ, de Joncheere K, Pedersen HB, Dedet G, Paris V, Mantel-Teeuwisse AK, Babar ZU; Scientific Programme Committee of the 2015 PPRI Conference.

J Pharm Policy Pract. 2016 Mar 15;9:9. doi: 10.1186/s40545-016-0056-8. eCollection 2016.

22.

Progress in increasing affordability of medicines for non-communicable diseases since the introduction of mandatory health insurance in the Republic of Moldova.

Ferrario A, Chitan E, Seicas R, Sautenkova N, Bezverhni Z, Kluge H, Habicht J.

Health Policy Plan. 2016 Jul;31(6):793-800. doi: 10.1093/heapol/czv136. Epub 2016 Feb 1.

23.

Serum BPIFB4 levels classify health status in long-living individuals.

Villa F, Malovini A, Carrizzo A, Spinelli CC, Ferrario A, Maciąg A, Madonna M, Bellazzi R, Milanesi L, Vecchione C, Puca AA.

Immun Ageing. 2015 Dec 15;12:27. doi: 10.1186/s12979-015-0054-8. eCollection 2015.

24.

Genetic Analysis Reveals a Longevity-Associated Protein Modulating Endothelial Function and Angiogenesis.

Villa F, Carrizzo A, Spinelli CC, Ferrario A, Malovini A, Maciąg A, Damato A, Auricchio A, Spinetti G, Sangalli E, Dang Z, Madonna M, Ambrosio M, Sitia L, Bigini P, Calì G, Schreiber S, Perls T, Fucile S, Mulas F, Nebel A, Bellazzi R, Madeddu P, Vecchione C, Puca AA.

Circ Res. 2015 Jul 31;117(4):333-45. doi: 10.1161/CIRCRESAHA.117.305875. Epub 2015 Jun 1.

25.

Investigational therapies targeting lymphocyte antigens for the treatment of non-Hodgkin's lymphoma.

Merli M, Ferrario A, Maffioli M, Arcaini L, Passamonti F.

Expert Opin Investig Drugs. 2015;24(7):897-912. doi: 10.1517/13543784.2015.1038342. Epub 2015 Apr 21. Review.

PMID:
25900401
26.

Exome sequencing of a family with lone, autosomal dominant atrial flutter identifies a rare variation in ABCB4 significantly enriched in cases.

Maciąg A, Villa F, Ferrario A, Spinelli CC, Carrizzo A, Malovini A, Torella A, Montenero C, Parisi A, Condorelli G, Vecchione C, Nigro V, Montenero AS, Puca AA.

BMC Genet. 2015 Feb 11;16:15. doi: 10.1186/s12863-015-0177-0.

27.

Everolimus in diffuse large B-cell lymphomas.

Merli M, Ferrario A, Maffioli M, Arcaini L, Passamonti F.

Future Oncol. 2015;11(3):373-83. doi: 10.2217/fon.14.264. Review.

PMID:
25675120
28.

Return to work after organ transplantation: a cross-sectional study on working ability evaluation and employment status.

Ferrario A, Verga FC, Piolatto PG, Pira E.

Transplant Proc. 2014 Dec;46(10):3273-7. doi: 10.1016/j.transproceed.2014.08.038.

PMID:
25498037
29.

A G613A missense in the Hutchinson's progeria lamin A/C gene causes a lone, autosomal dominant atrioventricular block.

Villa F, Maciąg A, Spinelli CC, Ferrario A, Carrizzo A, Parisi A, Torella A, Montenero C, Condorelli G, Vecchione C, Nigro V, Montenero AS, Puca AA.

Immun Ageing. 2014 Nov 26;11(1):19. doi: 10.1186/s12979-014-0019-3. eCollection 2014.

30.

Dealing with uncertainty and high prices of new medicines: a comparative analysis of the use of managed entry agreements in Belgium, England, the Netherlands and Sweden.

Ferrario A, Kanavos P.

Soc Sci Med. 2015 Jan;124:39-47. doi: 10.1016/j.socscimed.2014.11.003. Epub 2014 Nov 5.

PMID:
25461860
31.

The economic burden of diabetes in India: a review of the literature.

Yesudian CA, Grepstad M, Visintin E, Ferrario A.

Global Health. 2014 Dec 2;10:80. doi: 10.1186/s12992-014-0080-x. Review.

32.

Evidence-based decision making in healthcare in Central Eastern Europe.

Ferrario A, Baltezarević D, Novakovic T, Parker M, Samardzic J.

Expert Rev Pharmacoecon Outcomes Res. 2014 Oct;14(5):611-5. doi: 10.1586/14737167.2014.946014. Epub 2014 Aug 4. No abstract available.

PMID:
25090222
33.

Primary leptomeningeal CNS lymphoma presenting as bilateral facial nerve palsy.

Gastaldi M, Ferrario A, Basilico C, Merli M, Mauri M, Tibiletti MG, Passamonti F, Franciotta D, Bono G.

J Neurol Sci. 2014 Sep 15;344(1-2):234-5. doi: 10.1016/j.jns.2014.06.036. Epub 2014 Jun 24. No abstract available.

PMID:
24996491
34.
35.

An in-depth analysis of pharmaceutical regulation in the Republic of Moldova.

Ferrario A, Sautenkova N, Bezverhni Z, Seicas R, Habicht J, Kanavos P, Safta V.

J Pharm Policy Pract. 2014 May 1;7:4. doi: 10.1186/2052-3211-7-4. eCollection 2014.

36.

Challenges in diabetes management in Indonesia: a literature review.

Soewondo P, Ferrario A, Tahapary DL.

Global Health. 2013 Dec 3;9:63. doi: 10.1186/1744-8603-9-63. Review.

37.

Epidemiology, management, complications and costs associated with type 2 diabetes in Brazil: a comprehensive literature review.

Bertoldi AD, Kanavos P, França GV, Carraro A, Tejada CA, Hallal PC, Ferrario A, Schmidt MI.

Global Health. 2013 Dec 3;9:62. doi: 10.1186/1744-8603-9-62. Review.

38.

Successful treatment of post-neurosurgical multidrug-resistant Pseudomonas aeruginosa meningo-encephalitis with combination therapy of colistin, rifampicin and doripenem.

Morelli P, Ferrario A, Tordato F, Piazza A, Casari E.

J Antimicrob Chemother. 2014 Mar;69(3):857-9. doi: 10.1093/jac/dkt437. Epub 2013 Oct 29. No abstract available.

PMID:
24169582
39.

Personalizing health care: feasibility and future implications.

Godman B, Finlayson AE, Cheema PK, Zebedin-Brandl E, Gutiérrez-Ibarluzea I, Jones J, Malmström RE, Asola E, Baumgärtel C, Bennie M, Bishop I, Bucsics A, Campbell S, Diogene E, Ferrario A, Fürst J, Garuoliene K, Gomes M, Harris K, Haycox A, Herholz H, Hviding K, Jan S, Kalaba M, Kvalheim C, Laius O, Lööv SA, Malinowska K, Martin A, McCullagh L, Nilsson F, Paterson K, Schwabe U, Selke G, Sermet C, Simoens S, Tomek D, Vlahovic-Palcevski V, Voncina L, Wladysiuk M, van Woerkom M, Wong-Rieger D, Zara C, Ali R, Gustafsson LL.

BMC Med. 2013 Aug 13;11:179. doi: 10.1186/1741-7015-11-179. Review.

40.

Dabigatran - a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs.

Malmström RE, Godman BB, Diogene E, Baumgärtel C, Bennie M, Bishop I, Brzezinska A, Bucsics A, Campbell S, Ferrario A, Finlayson AE, Fürst J, Garuoliene K, Gomes M, Gutiérrez-Ibarluzea I, Haycox A, Hviding K, Herholz H, Hoffmann M, Jan S, Jones J, Joppi R, Kalaba M, Kvalheim C, Laius O, Langner I, Lonsdale J, Lööv SÄ, Malinowska K, McCullagh L, Paterson K, Markovic-Pekovic V, Martin A, Piessnegger J, Selke G, Sermet C, Simoens S, Tulunay C, Tomek D, Vončina L, Vlahovic-Palcevski V, Wale J, Wilcock M, Wladysiuk M, van Woerkom M, Zara C, Gustafsson LL.

Front Pharmacol. 2013 May 14;4:39. doi: 10.3389/fphar.2013.00039. eCollection 2013.

41.

Looking for familial nodular lymphocyte-predominant Hodgkin lymphoma.

Merli M, Maffioli M, Ferrario A, Passamonti F.

Am J Hematol. 2013 Aug;88(8):719-20. doi: 10.1002/ajh.23482. Epub 2013 Jul 3. No abstract available.

42.

Novel agents in indolent lymphomas.

Merli M, Ferrario A, Basilico C, Maffioli M, Caramazza D, Appio L, Arcaini L, Passamonti F.

Ther Adv Hematol. 2013 Apr;4(2):133-48. doi: 10.1177/2040620712466865.

43.

Higher US branded drug prices and spending compared to other countries may stem partly from quick uptake of new drugs.

Kanavos P, Ferrario A, Vandoros S, Anderson GF.

Health Aff (Millwood). 2013 Apr;32(4):753-61. doi: 10.1377/hlthaff.2012.0920.

PMID:
23569056
44.

Diabetes management in Thailand: a literature review of the burden, costs, and outcomes.

Deerochanawong C, Ferrario A.

Global Health. 2013 Mar 14;9:11. doi: 10.1186/1744-8603-9-11. Review.

45.

Vascular ageing: the role of oxidative stress.

Puca AA, Carrizzo A, Villa F, Ferrario A, Casaburo M, Maciąg A, Vecchione C.

Int J Biochem Cell Biol. 2013 Mar;45(3):556-9. doi: 10.1016/j.biocel.2012.12.024. Epub 2013 Jan 7. Review.

PMID:
23305730
46.

Endothelial nitric oxide synthase, vascular integrity and human exceptional longevity.

Puca AA, Carrizzo A, Ferrario A, Villa F, Vecchione C.

Immun Ageing. 2012 Nov 15;9(1):26. doi: 10.1186/1742-4933-9-26.

47.

Candidemia: species involved, virulence factors and antimycotic susceptibility.

De Luca C, Guglielminetti M, Ferrario A, Calabr M, Casari E.

New Microbiol. 2012 Oct;35(4):459-68. Epub 2012 Oct 1.

48.

Clinical predictors of outcome in MPN.

Passamonti F, Maffioli M, Merli M, Ferrario A, Caramazza D.

Hematol Oncol Clin North Am. 2012 Oct;26(5):1101-16. doi: 10.1016/j.hoc.2012.07.009. Epub 2012 Aug 28. Review.

PMID:
23009940
49.

Comparison of triple-lumen central venous catheters impregnated with silver nanoparticles (AgTive®) vs conventional catheters in intensive care unit patients.

Antonelli M, De Pascale G, Ranieri VM, Pelaia P, Tufano R, Piazza O, Zangrillo A, Ferrario A, De Gaetano A, Guaglianone E, Donelli G.

J Hosp Infect. 2012 Oct;82(2):101-7. doi: 10.1016/j.jhin.2012.07.010. Epub 2012 Aug 28.

PMID:
22938728
50.

The application of genetics approaches to the study of exceptional longevity in humans: potential and limitations.

Ferrario A, Villa F, Malovini A, Araniti F, Puca AA.

Immun Ageing. 2012 Apr 23;9(1):7. doi: 10.1186/1742-4933-9-7.

Supplemental Content

Loading ...
Support Center